The short answer: Keyhole surgery — laparoscopic or robotic — is possible for most women with early womb (endometrial) cancer, meaning cancer that appears on scans to be confined to the womb. Randomised trials, starting with the LAP2 trial (first results in 2009), found that for these women it controls the cancer about as well as open surgery, with a shorter hospital stay. It may not be possible if the womb is very large, the cancer has spread, or heart or lung problems make the position needed during surgery unsafe. In Hindi this cancer is often called bachedani ka cancer (बच्चेदानी का कैंसर).
On this page
- Surgery as the Standard of Care for Endometrial Cancer
- Why Minimally Invasive Surgery Is the Preferred Approach
- Robotic Surgery: Precision for Complex Cases
- Sentinel Lymph Node Mapping
- When Adjuvant Treatment Is Needed
Surgery as the Standard of Care for Endometrial Cancer
For most women with uterine (endometrial) cancer, surgery is the primary — and often the only — treatment required. The surgical procedure consists of a total hysterectomy, bilateral salpingo-oophorectomy (removing the womb, cervix, both tubes and both ovaries), and checking the lymph nodes. Roughly 70% of women are diagnosed with Stage I disease (cancer still confined to the womb), where surgery alone achieves five-year survival rates exceeding 90%.
Why Minimally Invasive Surgery Is the Preferred Approach
The LAP2 trial — a large American randomised trial of about 2,600 women with early-stage (clinical stage I to IIA) endometrial cancer, published in 2009 with survival results in 2012 — found that laparoscopic (keyhole) hysterectomy controls the cancer about as well as open surgery, with fewer complications and a shorter hospital stay. Two limits are worth knowing: it compared laparoscopic with open surgery (robotic surgery was not tested), and about 1 in 4 keyhole operations in the trial had to be switched to open surgery, more often in women with a higher body weight. In everyday practice, for suitable women, keyhole surgery usually means:
- Shorter hospital stay (typically 1–2 nights vs 4–5 for laparotomy)
- Less blood loss and lower transfusion rates
- Fewer wound complications — important in obese patients
- Faster return to normal activities and work
- Equivalent lymph node yield and survival outcomes
Because endometrial cancer is more common in older women, women with a higher body weight, and women with conditions such as diabetes or high blood pressure, the reduced physiological stress of laparoscopic surgery often makes it the safer option for women who would be higher-risk candidates for open laparotomy.
When keyhole surgery may not be possible: if the womb is too large to be removed whole (in cancer surgery the womb should not be cut into pieces inside the body), if scans suggest the cancer has spread outside the womb, if there are very dense adhesions from earlier operations, or if heart or lung problems make the steep head-down position and the gas used to inflate the abdomen unsafe. Open surgery is then usually advised. For how this choice is made, see open versus robotic surgery for uterine cancer; for the full picture of diagnosis and treatment, see our guide to uterine cancer care.
Robotic Surgery: Precision for Complex Cases
Robotic-assisted laparoscopic hysterectomy (using the da Vinci surgical system) extends the benefits of minimally invasive surgery to technically challenging cases — morbidly obese patients, those with extensive adhesions, or cases requiring para-aortic lymphadenectomy. The robotic platform provides 3D high-definition visualisation, wristed instrument tips with seven degrees of freedom, and tremor filtration. Robotic surgery is not needed for every woman: in straightforward cases, standard laparoscopy gives similar results. Read more about when robotic surgery is appropriate, and if you are deciding about an operation, these questions to ask before robotic hysterectomy.
Sentinel Lymph Node Mapping
Sentinel lymph node (SLN) mapping — injecting indocyanine green (ICG) dye into the cervix at the start of surgery and identifying the first lymph nodes to receive drainage — has emerged as a less morbid alternative to systematic pelvic lymphadenectomy, with comparable staging accuracy. It is now endorsed by ESGO and NCCN guidelines for Stage I–II low-to-intermediate risk endometrial cancer. Robotic systems have a built-in near-infrared camera that shows the dye clearly; similar cameras are also available for standard laparoscopy.
When Adjuvant Treatment Is Needed
After surgery, final pathological staging determines whether adjuvant treatment (radiation therapy, chemotherapy, or both) is recommended. High-risk features include the cancer growing deep into the womb muscle (deep myometrial invasion), faster-growing cancer types (Grade 3, clear-cell or serous), spread into the cervix, and cancer found in the lymph nodes. The decision is made in a multidisciplinary oncology meeting — a joint assessment by the surgeon, medical oncologist, and radiation oncologist.
For a consultation about minimally invasive uterine cancer surgery in Ahmedabad, contact Dr. Nishtha Tripathi Patel at +91 76988 00333.